Victoza and Dalfampridine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Victoza (liraglutide) and Dalfampridine (dalfampridine). Common drug interactions include muscular weakness among females and multiple sclerosis among males.

The phase IV clinical study analyzes what interactions people have when they take Victoza and Dalfampridine. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Victoza?

Victoza has active ingredients of liraglutide. It is often used in diabetes. eHealthMe is studying from 42,880 Victoza users. Check the latest studies of Victoza.

What is Dalfampridine?

Dalfampridine has active ingredients of dalfampridine. eHealthMe is studying from 9,658 Dalfampridine users. Check the latest studies of Dalfampridine.

On Jul, 31, 2026

13 people who take Victoza and Dalfampridine together, and have interactions are studied.

Victoza and Dalfampridine drug interactions.

What are the common drug interactions of Victoza and Dalfampridine, by gender? *:

female:

Muscular weakness (muscle weakness)
Pain
Arthropathy
Balance disorder
Insomnia (sleeplessness)
Intervertebral disc protrusion (spinal disc protrusion)
Open fracture
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Lower limb fracture
Fatigue (feeling of tiredness)

male:

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Asthenia (weakness)
Drug ineffective
Dysgraphia (impaired ability to learn to write)
Gait disturbance
Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)

What are the common drug interactions of Victoza and Dalfampridine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Gait disturbance
Muscular weakness (muscle weakness)
Arthropathy
Insomnia (sleeplessness)
Intervertebral disc protrusion (spinal disc protrusion)
Pain
Fall
Fatigue (feeling of tiredness)
Arthralgia (joint pain)
Joint instability (a condition in which the joints aren't sufficiently supported)

50-59:

Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Gait disturbance
Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
Pain

60+:

Ankle fracture
Asthenia (weakness)
Drug ineffective
Dysgraphia (impaired ability to learn to write)
Gait disturbance
Lower limb fracture
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 12 people, 92.31%
Gait Disturbance: 4 people, 30.77%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 7.69%
High Blood Pressure: 1 person, 7.69%
Gastritis (inflammation of stomach): 1 person, 7.69%
Erection Problems: 1 person, 7.69%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 1 person, 7.69%
Depression: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Victoza and Dalfampridine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously